[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100527479":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":22,"locations":31,"responsibleParty":44,"collaborators":10,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University of Central Florida","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Pancreatic Ductal Adenocarcinoma",null,[12],"Other: Non-Human Subject Research study.",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"Non-Human Subject Research study.","This is a Non-Human Subject Research study. There is no intervention. All participants are de-identified.",[9],[19],{"name":20,"affiliation":5,"role":21},"Kersten Schroeder, PhD","PRINCIPAL_INVESTIGATOR",[23,28],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Amoy Fraser, PhD, CCRP, PMP","CONTACT","4072668742","amoy.fraser@ucf.edu",{"name":29,"role":25,"phone":26,"phoneExt":10,"email":30},"Erica Martin, B.S.","erica.martin@ucf.edu",[32],{"facility":5,"status":33,"city":34,"state":35,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":10},"RECRUITING","Orlando","Florida","32816","United States",{"type":39,"coordinates":40},"Point",[41,42],-81.37924,28.53834,{"lat":42,"lon":41},{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100527479",false,"NCT06148298","Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer","Cell-free Chromatin Immunoprecipitation (CfChIP) from Blood Plasma As a Diagnostic and Prognostic Tool in Pancreatic Ductal Adenocarcinoma","Inclusion Criteria:\n\n* 18 years old or older\n* Pancreatic cancer patients\n\nExclusion Criteria:\n\n* Children may not register\n* Persons who are unable to consent may not register","ALL","18 Years",{"count":55,"type":56},24,"ESTIMATED","OBSERVATIONAL","The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples.\n\nThis is a Non-Human Subject Research study. All participants are de-identified.",[60],"Cancer of Pancreas",[62,63],"cancer","pancreas","2024-12-03",{"date":66,"type":67},"2024-12-06","ACTUAL",{"date":69,"type":67},"2023-05-24",{"date":71,"type":56},"2025-05",{"name":5,"class":6},1]